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The aryl hydrocarbon receptor (AHR) is a vertebrate protein that mediates the toxic and adaptive responses to dioxins
and related environmental pollutants. In an effort to better understand the details of this signal transduction pathway,
we employed the yeast S. cerevisiae as a model system. Through the use of arrayed yeast strains harboring ordered
deletions of open reading frames, we determined that 54 out of the 4,507 yeast genes examined significantly influence
AHR signal transduction. In an effort to describe the relationship between these modifying genes, we constructed a
network map based upon their known protein and genetic interactions. Monte Carlo simulations demonstrated that
this network represented a description of AHR signaling that was distinct from those generated by random chance. The
network map was then explored with a number of computational and experimental annotations. These analyses
revealed that the AHR signaling pathway is defined by at least five distinct signaling steps that are regulated by
functional modules of interacting modifiers. These modules can be described as mediating receptor folding, nuclear
translocation, transcriptional activation, receptor level, and a previously undescribed nuclear step related to the
receptor’s Per–Arnt–Sim domain.
Introduction
The aryl hydrocarbon receptor (AHR) is a ligand-activated
transcription factor found in a variety of vertebrate species.
The AHR is a prototype member of the Per–Arnt–Sim (PAS)
superfamily of signaling molecules. Members of this super-
family regulate cellular responses to a variety of environ-
mental stimuli, including pollutants, hypoxia, and external
light cues (Gu et al. 2000). Our initial interest in AHR biology
arose from its pivotal role in mediating the adaptive
metabolic response to both polycyclic aromatic hydrocarbons
(PAHs) and the toxic effects of more potent agonists like the
halogenated dioxins (Schmidt and Bradﬁeld 1996; Whitlock
1999). More recently, it has been observed that the AHR plays
an important role in normal vascular development, suggest-
ing the existence of an endogenous ligand (Lahvis et al. 2000).
From the broader perspective, the AHR can be viewed as a
prototype of all PAS protein signaling. That is, what we learn
about AHR biology will have a direct inﬂuence on how we
think about PAS-mediated hypoxia, circadian, and devel-
opmental pathways.
An initial understanding of AHR signal transduction has
resulted from the biochemical and molecular studies that
have been performed over the past two decades (Schmidt and
Bradﬁeld 1996; Whitlock 1999). The resultant model holds
that the unliganded AHR resides in the cytoplasm, where it is
associated with a dimer of the chaperone protein Hsp90 and
cochaperones such as ARA9/XAP2 and p23 (Pongratz et al.
1992; Carver and Bradﬁeld 1997; Ma and Whitlock 1997;
Meyer et al. 1998; Kazlauskas et al. 1999). Upon binding
ligands, the cytoplasmic AHR translocates to the nucleus,
where it dimerizes with another PAS protein known as ARNT.
The AHR–ARNT heterodimer then binds to speciﬁc dioxin-
responsive enhancers (DREs) and transactivates a battery of
genes encoding xenobiotic-metabolizing enzymes, most nota-
bly CYP1A1, CYP1A2, and CYP1B1 (Schmidt and Bradﬁeld
1996; Whitlock 1999). Transactivation of target genes has
been shown to be mediated through a variety of histone
acetyltransferases (HATs) and SWI/SNF coactivators, such as
SRC, p300/CBP, and BRG-1 (Kobayashi et al. 1997; Beischlag
et al. 2002; Wang and Hankinson 2002).
Although the initial model of AHR signaling provides a
valuable framework, its completeness has not yet been
assessed. That is, we have no estimates of the total number
of gene products involved in AHR signaling, nor can we be
sure we have identiﬁed all the important steps. Without these
estimates, it is difﬁcult to gauge how much or how little we
understand about this pathway. In an effort to address these
issues, we employed the comprehensive set of gene deletions
available in a yeast model system to systematically identify
gene products that inﬂuence AHR function. We then
employed a protein interaction network (PIN) strategy to
provide a framework to describe AHR signaling. By coupling
both computational and experimental annotations, we were
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Results
Rationale
A number of laboratories have demonstrated that the yeast
Saccharomyces cerevisiae is a valuable model system for the study
of signaling by mammalian nuclear receptors (Garabedian
and Yamamoto 1992; McEwan 2001). Although there is no
yeast ortholog of the AHR, it has been also shown that AHR
signaling can be recapitulated in yeast and that this system
can be used to identify novel players in AHR biology (Carver
et al. 1994; Whitelaw et al. 1995). The experimental
advantages of S. cerevisiae as a tool to study AHR signaling
are related to the yeast’s fundamental similarities with
mammalian systems, the more thorough characterization of
its smaller genome, and the availability of its speciﬁc genomic
tools, such as arrayed deletions of each individual open
reading frame (ORF) and large-scale databases describing
protein and genetic interactions (Winzeler et al. 1999;
Resnick and Cox 2000; Kennedy 2002; Mewes et al. 2002;
Xenarios et al. 2002). These convenient genomic tools allowed
us to employ a systematic approach to identify gene products
involved in the AHR pathway and to interpret them in the
context of a protein interaction network. Owing to a lack of
corresponding reagents/databases, such an approach is not
yet feasible for the study of AHR signaling in more complex
eukaryotic systems such as human or mouse.
Identification of AHR Modifiers by a High-Throughput
Deletion Array Screen
In earlier attempts to identify AHR modiﬁers in yeast, it
was demonstrated that genetic screens can be performed
more efﬁciently by using an AHR construct that is fused to
the DNA-binding domain of the bacterial LexA protein
(AHR–LexA) (Carver et al. 1994; Whitelaw et al. 1995). This
chimeric system removes the requirement for ARNT and
allows our screens to be more speciﬁc for those mutations/
modiﬁers that directly inﬂuence AHR function. Using this
system, we set out to identify gene products that play
important roles in AHR signaling (Figure 1A).
To accomplish this screen, we employed the yeast deletion
strains made available by the Saccharomyces Genome Deletion
Project (Winzeler et al. 1999). We developed a high-
throughput approach to efﬁciently transform each deletion
strain with two plasmids, one harboring the AHR–LexA
chimera (pCEN-AHR) and the other, a LexA operator-driven
LacZ reporter. Of the 4,695 available deletion strains, 4,507
(96%) were successfully transformed with the complete AHR
signaling system (i.e., both plasmids). In the primary screen,
we selected transformants that exhibited a 4-fold or greater
change in AHR response as compared to the wild-type (wt)
BY4742 strain (p , 10
–6). To minimize false positives, we
selected clones that inﬂuenced signaling at no less than two of
the six concentrations of agonist tested. In addition, we
retested each positive strain in a secondary screen with
another AHR system containing the same LacZ reporter and
a high-copy AHR–LexA chimera (pAHR) (Carver 1996). By
these criteria, 92 deletion strains were identiﬁed that
reproducibly displayed a signiﬁcant change in AHR signaling
as compared to the wt strain (Table S1).
To eliminate those deletions that inﬂuenced the AHR
pathway in a nonspeciﬁc manner, each of the 92 deletion
strains was examined with a control plasmid pGal4TAD (see
Materials and Methods). This construct harbors the tran-
scriptional activation domain (TAD) of Gal4p fused to the
LexA DNA-binding domain and was cotransformed into each
deletion strain with the LacZ reporter (Figure 1B). Of the 92
deletions, 38 were observed to also inﬂuence pGal4TAD
signaling. We concluded that these deletions either repre-
sented general players in both pathways or exhibited non-
speciﬁc effects through their inﬂuence on, e.g., the common
LexA domain, plasmid maintenance, or cell growth rate.
Therefore, the inclusion of the pGal4TAD control led us to
eliminate 38 nonspeciﬁc factors and identify 54 deletions that
appeared to inﬂuence the AHR pathway in a speciﬁc manner.
Of these ‘‘AHR-speciﬁc’’ factors, Hsc82p and Cpr7p were
previously described AHR modiﬁers, and the other 52 were
novel (Carver et al. 1994; Whitelaw et al. 1995; Miller 2002)
(Table S2). The analysis of the annotated function of these
AHR modiﬁers revealed that they were associated with a great
variety of cellular functions (Table S3). For many of these
annotations, their direct association with AHR signaling
appeared elusive. Therefore, in order to appreciate the
Figure 1. High-Throughput Deletion Array Screen for AHR Modifiers
(A) The ﬂow chart of the deletion array screen. Each individual
deletion strain was transformed with the AHR–LexA chimera and
LacZ reporter constructs using a 96-well microtiter plate trans-
formation approach. The AHR-dependent reporter activity of each
deletion strain was examined with a 384-well plate-based ﬂuorescence
assay method. A total of 92 deletion strains were identiﬁed that
displayed AHR signaling signiﬁcantly different from the wt control.
(B) Identiﬁcation of ‘‘AHR-speciﬁc’’ modiﬁers. The effect of modiﬁer
deletions on the AHR pathway was compared with their effect on a
Gal4TAD control pathway. It was found that 54 deletions inﬂuenced
AHR signaling speciﬁcally, whereas 38 deletions corresponded to
general factors. See text for details.
DOI: 10.1371/journal.pbio.0020065.g001
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The AHR Networkfunction of identiﬁed modiﬁers in the AHR pathway, an
information framework was required to put them in context.
Portrayal of the AHR–PIN
Recent experiments from a number of laboratories have
provided data to support the idea that protein interaction
network (PIN) can be used to portray the workings of
complex biological systems (Schwikowski et al. 2000; Ge et
al. 2001; Ideker et al. 2001; Tong et al. 2002). To investigate
how identiﬁed modiﬁers and their interactions inﬂuence
AHR signaling, we constructed a modiﬁer network (AHR–
PIN) based on known protein and genetic interactions
derived from the DIP and MIPS databases (Mewes et al.
2002; Xenarios et al. 2002). Our AHR–PIN map is comprised
of ‘‘nodes’’ and ‘‘links.’’ A ‘‘node’’ is a graphic depiction of a
protein or locus, and a ‘‘link’’ is a line between two nodes in
the map that depicts the known interaction between them. As
yeast protein–protein interactions identiﬁed to date are still
far from saturating and are heavily biased towards proteins of
high abundance, genetic interactions were also included in
the network building as a complement (Tong et al. 2002; von
Mering et al. 2002). In the AHR–PIN, protein interactions are
depicted with black lines, and genetic interactions are labeled
in red. In addition, nodes also come in two types, ‘‘M-nodes’’
and ‘‘I-nodes.’’ We refer to the protein or locus that has an
identiﬁed effect on the AHR pathway as the ‘‘M-node,’’ or
modiﬁer node, and refer to the nonmodiﬁer node that is
required on a path to connect two M-nodes as the ‘‘I-node,’’
or intervening node.
In an effort to determine the most informative PIN, we
examined how the structure and complexity of the map was
inﬂuenced by the choice of the maximally allowed number of
links between any two M-nodes (we refer to this value as
Dmax). One common feature of AHR–PINs with Dmax values
greater than 1 was that the majority of M-nodes were
interconnected in a single large network with no breaks
(Figure 2A–2C). For convenience, we refer to this single large
network simply as the AHR–PIN in following discussions.
When Dmax was set at low stringency (Dmax  3), the
representation of M-nodes in AHR–PIN was high. For
example, at Dmax = 3, 46 of 54 M-nodes were included.
However, AHR–PINs resulting from these inclusive, yet low-
stringency conditions exhibited high complexity, which made
it impossible to assess the interactions visually (Figure 2A and
2B). When Dmax was set at higher stringency (Dmax = 2), the
resultant AHR–PIN now comprised 34 closely interconnected
M-nodes and was much easier to visualize (Figure 2C; Table
S4). Further simpliﬁcation of the AHR–PIN with Dmax =1
was of little utility because it resulted in a large proportion of
isolated M-nodes, with the largest cluster containing only
three M-nodes (Figure 2D).
The AHR–PIN Is Distinct from Random PINs
To examine the statistical signiﬁcance of the AHR–PINs,
we tested whether they could have been generated by random
chance. If the AHR–PIN represents a valid description of the
AHR pathway, it should comprise signiﬁcantly more inter-
connected M-nodes than would be interconnected by
Figure 2. AHR–PIN versus Random PINs
(A–D) AHR–PINs at various Dmax levels. AHR modiﬁers are highlighted with bigger green nodes. A total of 48, 46, 34, and three AHR modiﬁers
are interconnected in the AHR–PINs with Dmax values of 4, 3, 2, and 1, respectively.
(E–H) Distribution of random PINs at various Dmax levels in histogram. Each distribution graph represents 5,000 randomly generated PINs. The
density estimation curve (in red) is plotted on top of the histogram where applicable. The number of M-nodes in the AHR–PIN and the average
number of M-nodes in random networks are marked in each distribution graph. See text for details.
DOI: 10.1371/journal.pbio.0020065.g002
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The AHR Networkrandom chance. To test this idea, a Monte Carlo simulation
was conducted by generating 5,000 random PINs at each
Dmax setting. Each of these test PINs was constructed based
on 54 mock M-nodes randomly selected from genes
contained in the entire deletion set. To estimate the
statistical signiﬁcance of the AHR–PIN, the random graph
was deﬁned as the null distribution, and the p value for the
AHR–PIN at each Dmax was calculated from the fraction of
trials with a higher number of interconnected M-nodes
(Figure 2E–2H). The AHR–PIN at Dmax =1w a sn o t
statistically signiﬁcant compared to those generated at
random chance (p , 0.08; Figure 2H). However, at Dmax =
2, Dmax = 3, and Dmax = 4, the number of interconnected M-
nodes in the AHR–PIN was signiﬁcantly larger than that of
random PINs (p , 10
–4,1 0
–3, and 3 3 10
–3, respectively;
Figure 2E–2G). These observations were consistent with the
idea that AHR–PINs at these settings provide a biologically
meaningful description of AHR signaling.
For further exploration, we chose to focus on the network
with the greatest statistical signiﬁcance, i.e., the PIN
generated at Dmax = 2. In this AHR–PIN, 63.0% of the M-
nodes (34/54) are interconnected, while in corresponding
random PINs with mock M-nodes, this number drops to
18.5% (10/54). Although the AHR–PINs at Dmax = 3 and
Dmax = 4 also exhibited statistically signiﬁcant differences
from random PINs, these AHR–PINs were not considered
further for two reasons. First, these networks were visually
complex and could not be simply annotated in two
dimensions. Second, the ratios of interconnected M-nodes
in these AHR–PINs to those of random PINs were quite low
(1.3 and 1.2 for Dmax = 3 and Dmax = 4, respectively). This
observation suggests a much greater potential for displaying
false positive interactions at these settings as compared to the
AHR–PIN at Dmax = 2, where this ratio was 3.4 (34/10).
Modular Organization of AHR–PIN as Revealed by
Network Clustering
Our next objective was to use the PIN to enumerate and
deﬁne steps in AHR signaling. It has been suggested that PINs
exhibit a modular nature, with each module comprising
highly interconnected proteins of related cellular functions
(Hartwell et al. 1999; Schwikowski et al. 2000). Our hypothesis
was that functional modules in the AHR–PIN would
correspond to discrete steps in the mechanism of signaling.
To test this idea, we attempted to deﬁne the functional
modules using a number of computational and experimental
annotation approaches.
As a strictly computational approach, we attempted to
identify the functional modules in the AHR–PIN by a
network-clustering method (Rives and Galitski 2003). In brief,
an all-pairs-shortest-path distance matrix was generated for
every pair of nodes within the AHR–PIN (Dmax = 2). Each
distance (d) in the matrix refers to the length of the shortest
path between a pair of nodes in the full network space of
yeast genomic PIN and was transformed into an ‘‘association’’
value (1/d
2). The resultant pairwise association matrix was
used to identify network clusters in the AHR–PIN by a
hierarchical average-linkage clustering algorithm (Eisen et al.
1998; Rives and Galitski 2003). The cluster boundaries were
delimited by using a similar ‘‘tree-depth threshold’’ that was
set low enough to separate the largest cluster from others
(Figure 3A) (Rives and Galitski 2003). If we deﬁne a network
cluster to include at least two M-nodes, ten such clusters can
be identiﬁed (Figure 3A). Consistent with the modular PIN
hypothesis, we found that these clusters overlapped with ten
local areas (modules) in the AHR–PIN, with each module
comprised of two to six M-nodes (Figure 3B).
In an effort to deﬁne the function of these proposed
network modules, we asked whether each individual module
could be best described by a particular annotation. A module
is considered to be enriched for a given annotation if the
number of components known to have that function within
the module exceeds the number that could be expected from
random chance. It has been proposed that the degree of
enrichment for a given annotation can be measured by its
hypergeometric distribution (Tavazoie et al. 1999). Using this
approach, we calculated the annotation enrichment for each
of the ten protein modules in the AHR–PIN with the FunSpec
program (Table S5) (Robinson et al. 2002). As shown in Figure
3B, it was found that the AHR–PIN is organized by protein
modules that perform distinct cellular functions (e.g., protein
folding and chromatin modiﬁcation).
Functional Modules as Revealed by Their Influence on
Different AHR Domains
In an effort to test the predicted modules and deﬁne how
they inﬂuence AHR signaling, we annotated the AHR–PIN
using a number of independent functional tests. First, we
examined whether functional modules could be identiﬁed
based upon their inﬂuence on different domains of the AHR.
To this end, we examined the inﬂuence of each modiﬁer on
the signaling of a partial-deletion mutant, pAHRDPASB,
which contains the AHR’s transcriptionally active domain but
is missing those domains responsible for ligand binding and
Hsp90 interaction (Figure 4A). Of the 53 modiﬁer deletions
successfully transformed with the pAHRDPASB system, we
found that 25 deletions affected both the parent AHR and
the deletion mutant. This observation indicated that these 25
modiﬁers had an inﬂuence on the shared C-terminal TAD
region and not on the PASB domain (Figure 4A). These
modiﬁers were referred to as the ‘‘TAD inﬂuence group.’’
The remaining 28 deletions, which required the PASB
domain for their effect, were referred to as the ‘‘PASB
inﬂuence group.’’
When the AHR–PIN was annotated according to the
domain inﬂuence of each modiﬁer, it was found that
modiﬁers from the same domain inﬂuence group closely
interacted in the map. That is, the PASB inﬂuence group
resided in a single connected region, whereas the TAD
inﬂuence group occupied two peripheral regions (Figure 4B).
Interestingly, the PASB module was found to overlap with the
computationally identiﬁed clusters 1, 3, 5, 8, 9, and 10. For the
two TAD modules, one overlapped with cluster 6, and the
other with clusters 4 and 7. This overlap supported both the
computational and experimental annotations. For example,
the ‘‘chromatin modiﬁcation cluster,’’ 6, identiﬁed and
annotated computationally, was found to be associated with
the TAD inﬂuence group, deﬁned experimentally. Similarly,
the ‘‘protein folding cluster,’’ 5, was associated with the PASB
domain inﬂuence group. The PASB domain is known to
interact with the chaperone protein Hsp90, which plays a
signiﬁcant role in the folding of the mammalian AHR
(Pongratz et al. 1992; Carver et al. 1994; Whitelaw et al. 1995).
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Pharmacology
To further annotate the AHR–PIN, each of the 54 modiﬁers
was tested for its inﬂuence on AHR signaling (pAHR system)
at various agonist concentrations, times, and temperatures, as
well as after exposure to two distinct AHR agonists, a-
naphthoﬂavone (aNF) and b-naphthoﬂavone (bNF). The
relationship between each modiﬁer and signaling was then
examined using a hierarchical average-linkage clustering
algorithm (Eisen et al. 1998) (Figure 5A). It was found that
Figure 3. Functional Modules Identified by
Network Clustering
(A) Network clustering of AHR–PIN.
Protein nodes in the AHR–PIN (Dmax
= 2) were clustered by a hierarchical
clustering algorithm. A tree-depth
threshold was set to delimit cluster
boundaries (Rives and Galitski 2003).
Clusters with at least two M-nodes are
shown. See text for details.
(B) Overlay of the network clusters on
the AHR–PIN. The ten network clusters
correspond to ten local areas in the
AHR–PIN. Each network cluster (local
area) is labeled with its signiﬁcant func-
tional enrichment as calculated using the
FunSpec program (Robinson et al. 2002).
Color scheme. Nodes: modiﬁer deletions
that incurred down- and up-regulation
of AHR signaling are marked in green
and red, respectively. For intervening
nodes, essential genes are marked in gray
and nonessential genes in white. Links:
physical interactions are labeled in black
and genetic interactions in red. If both
interactions are available for a given
link, only the physical interaction is
shown. This color scheme is also applied
to Figures 4–7.
DOI: 10.1371/journal.pbio.0020065.g003
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The AHR Networkthe ﬁve major clusters corresponded to ﬁve closely intra-
connected local areas in the map, designated A, B, C, D, and E
(Figure 5B). Among them, modules A and C exhibited
signiﬁcant functional enrichment of protein folding and
transcriptional control, respectively (data not shown). When
the clustering result was overlaid upon the previous maps, it
was found that modules A, D, and E corresponded to the
PASB inﬂuence module, and modules B and C corresponded
to the TAD inﬂuence module (Figure 5B).
Functional Modules as Revealed by Their Influence on
AHR Localization
Lastly, we examined each modiﬁer’s inﬂuence on AHR’s
subcellular localization. This was accomplished using an
AHR–GFP fusion protein (pAHRGFP). When the wt strain
was transformed with the plasmid pAHRGFP, it was found
that the fusion protein was evenly distributed in the cell in
the absence of AHR agonist. In the presence of the agonist
bNF, the AHR–GFP protein translocated to the nucleus
(Figure 6A). To examine the inﬂuence of each modiﬁer on
this translocation process, the pAHRGFP construct was
transformed into each of the 54 modiﬁer deletion strains
and its localization was examined by ﬂuorescence microscopy
in the presence of agonist. Four localization phenotypes were
identiﬁed (Figure 6B). About 50% of the deletion strains
exhibited AHR translocation similar to that observed in the
wt strain (group I). Approximately 30% of the strains were
found to contain a marked reduction in the level of AHR
protein in the cell (group II). Approximately 10% of the
deletion strains displayed receptor aggregates in the cell
(group III). The ﬁnal 10% of the deletion strains displayed a
normal level of AHR protein, but the receptor failed to
translocate into the nucleus in the presence of agonist (group
IV). When overlaid with the previously determined exper-
imental layers, group I was found to overlap with the modules
of C and D, and groups II, III, and IV corresponded to
modules B, A, and E, respectively (Figure 6C). According to
this overlap, module B can be further described as being
associated with the regulation of receptor level in the cell,
and module E is associated with the regulation of nuclear
translocation of the AHR (Figure 6C).
Discussion
Modifier Identification
Our initial objective was to identify the number of loci that
are required for AHR signal transduction. In this regard, our
high-throughput deletion screen identiﬁed 52 novel and two
known AHR modiﬁers. Although this is a surprisingly large
number of modiﬁers for the function of a single protein, it is
Figure 4. Functional Modules Identified by
the ‘‘Domain Influence’’
(A) Identiﬁcation of domain inﬂuencing
groups. The effects of modiﬁer deletions
on the signaling of AHR and AHRDPASB
were compared in parallel. It was found
that 28 modiﬁers were required for the
function of the PASB domain (i.e., their
deletions affected the AHR, but not the
AHRDPASB). The other 25 modiﬁers
were found to be required for the shared
TAD region (i.e., their deletions affected
the signaling of both AHR and
AHRDPASB).
(B) Overlay of the ‘‘domain inﬂuence’’
layer (blue boundary) and the network-
clustering layer (shadowed) on the AHR–
PIN. The PASB inﬂuence group corre-
sponds to a central region in the AHR–
PIN. The TAD inﬂuence group corre-
sponds to two peripheral areas. Occa-
sional outlier nodes are marked with
their corresponding module names.
DOI: 10.1371/journal.pbio.0020065.g004
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The AHR Networkprobably an underestimate since the deletion screen cannot
identify modiﬁers that are encoded by essential genes.
Moreover, our criteria of including only strong modiﬁers
(inﬂuence of 4-fold compared to control) may have caused us
to miss some important modiﬁers of this pathway. Never-
theless, the number of AHR modiﬁer loci reported here is
approximately 10-fold greater than what has been reported
using mammalian cell culture and animal models (Schmidt
and Bradﬁeld 1996; Whitlock 1999).
Once we identiﬁed these AHR modiﬁers in yeast, we sought
a way to position and characterize them in the context of the
AHR pathway. Given the idea that PINs can be used to
portray the cellular workings, we attempted to use our
deletion data to generate and annotate an AHR–PIN
(Hartwell et al. 1999; Schwikowski et al. 2000; Ge et al. 2001;
Ideker et al. 2001; Tong et al. 2002). To construct the AHR–
PIN, the yeast genomic PIN was decomposed by extracting
those nodes/links relevant to AHR modiﬁers. To test the
utility of the resultant AHR–PIN, a series of Monte Carlo
simulations were carried out. It was demonstrated that when
Dmax was set at 2, 3, or 4, the resultant AHR–PIN was of a
complexity that could not have resulted from random chance.
Furthermore, the comparison of various simulations at
different Dmax settings guided us to select the linking
parameter at Dmax = 2. This setting of intervening links
resulted in the highest level of statistical signiﬁcance,
displayed the lowest potential for false positive interactions,
and decreased the map’s visual complexity to a level that was
readily understood in a two-dimensional map.
The Modular Structure of AHR–PIN Reveals Five Discrete
Steps in Signaling
Our analysis of the AHR–PIN revealed an underlying
modular structure. That is, there are areas in the AHR–PIN
that display high interconnectedness of nodes, and these
regions represent functionally related modiﬁers. The modu-
larity of AHR–PIN was revealed by both computational and
functional tests. In our initial computational approach, a
total of ten clusters were identiﬁed, and the functional
enrichment of each cluster was calculated by hypergeometric
distribution (Tavazoie et al. 1999; Robinson et al. 2002).
Although the computational approaches of module iden-
Figure 5. Functional Modules Revealed by
Effect on AHR Pharmacology
(A) Cluster analysis of the effect of
modiﬁer deletion on AHR pharmacol-
ogy. AHR signaling was examined at
various doses, timepoints, and temper-
atures, and with the two AHR agonists
bNF and aNF. The inﬂuence of modiﬁer
deletion on the dose-response of the
AHR was analyzed by a hierarchical
clustering algorithm. Rows in the clus-
tering diagram represent modiﬁer dele-
tions. Columns correspond to
experimental conditions. Green and red
indicate down- and up-regulated AHR
signaling, respectively. Color brightness
is proportional to fold change. Black
indicates wt signaling. Sparse gray boxes
represent missing datapoints. (Insert)
Diagram of corresponding dose-re-
sponse curves of the wt strain and the
average of cluster C.
(B) Overlay of the ‘‘pharmacology clus-
tering’’ layer (shadowed, black boundary)
and ‘‘domain inﬂuence’’ layer (blue
boundary) on the AHR–PIN. The major
pharmacology clusters are coincident
with ﬁve local areas in the AHR–PIN.
In addition, clusters A, D, and E corre-
spond to the PASB inﬂuence module,
and clusters B and C correspond to the
TAD inﬂuence module. Functional an-
notations determined by pharmacology
clustering are indicated in black, and
those derived from domain inﬂuencing
are indicated in blue. Occasional outlier
nodes are marked with their correspond-
ing module designation. See the legend
of Figure 3 for the color scheme of the
nodes and links.
DOI: 10.1371/journal.pbio.0020065.g005
PLoS Biology | http://biology.plosjournals.org March 2004 | Volume 2 | Issue 3 | Page 0361
The AHR Networktiﬁcation and annotation were useful in hypothesis gener-
ation, they did not provide a direct description of AHR
signaling. Therefore, we set out to annotate the AHR–PIN
with a number of functional tests. In our ﬁrst annotation
experiment (‘‘domain inﬂuence’’), we found that the AHR–
PIN could be divided into three discrete functional modules
(i.e., one module that inﬂuenced the PASB domain and two
modules that inﬂuenced the C-terminal domain we referred
to as TAD). Additionally, each of these modules was found to
overlap with one to several network clusters (see Figure 4).
This tight overlay of functional data with highly intercon-
nected regions in the AHR–PIN also held true when we
applied annotations for pharmacological clustering and
subcellular localization studies (see Figures 5 and 6). Given
the overlay of these annotations derived from both functional
and computational tests, we conclude that the AHR–PIN
provides a biologically meaningful representation of the
regulatory network of AHR signaling (Figure 7A). Moreover,
based upon the combined annotations for each individual
module, we propose that AHR signal transduction is
regulated at ﬁve discrete steps: (1) receptor folding, (2)
receptor translocation, (3) receptor transcriptional activa-
tion, (4) receptor level, and (5) a previously undescribed
signaling event related to the PASB domain (Figure 7B).
Figure 6. Functional Modules Identified by
the ‘‘Localization Influence’’
(A) The AHR–GFP fusion protein trans-
locates to nucleus in the presence of
agonist bNF. Nucleus position in the cell
was conﬁrmed by DAPI staining (data
not shown). Dimethyl sulfoxide (DMSO)
is a vehicle control for bNF.
(B) Classiﬁcation of modiﬁer deletion
strains according to AHR–GFP pheno-
type (with bNF). Group I displays wt
phenotype. Group II contains decreased
level of receptor protein. Group III
contains aggregated misfolded receptor.
Group IV displays the AHR that is not
capable of translocating to the nucleus.
(C) Overlay of ‘‘localization inﬂuence’’
layer (shadowed, red boundary) and the
‘‘pharmacology clustering’’ layer (black
boundary) on the AHR–PIN. Group I
corresponds to modules C and D.
Groups II, III, and IV overlap with
modules of B, A, and E, respectively.
Functional annotations determined by
localization inﬂuence are indicated in
red, and those derived from pharmacol-
ogy clustering and domain inﬂuencing
studies are indicated in black. Occa-
sional outlier nodes are noted with their
corresponding module designation. See
the legend of Figure 3 for the color
scheme of the nodes and links.
DOI: 10.1371/journal.pbio.0020065.g006
PLoS Biology | http://biology.plosjournals.org March 2004 | Volume 2 | Issue 3 | Page 0362
The AHR NetworkThe AHR Folding Module
A module that regulates AHR folding was identiﬁed by the
known activities of its constituents, as well as the appearance
of receptor aggregates when these modiﬁers were absent (see
Figure 6B, group III). Given that AHR folding has been well
studied over the past 15 years, examination of this module
provided insight into the ﬁdelity of our screen and the
transference of our observations to the mammalian system.
For example, two known modiﬁers were identiﬁed by our
high-throughput screen: Hsc82p (homolog of human Hsp90)
and Cpr7p (homolog of human Cyp40) (Pongratz et al. 1992;
Miller 2002). In addition, we identiﬁed a previously unknown
player in the AHR folding pathway, the chaperone protein
Sti1p (homolog of human p60/HOP). Sti1p/p60 has been
shown to be an essential component of the glucocorticoid
receptor signaling pathway, where it is required to form an
Hsp90 chaperone complex (Chang et al. 1997; Dittmar and
Pratt 1997). By analogy, we propose that Sti1p/p60 is involved
in the formation of an Hsp90cochaperone complex that is
essential for the proper folding of the AHR. Finally, our
analysis of this module suggests that a number of proteins not
known to be chaperones are involved in receptor folding.
These proteins include Sec28p and possibly Rpl19b.
The AHR folding module can also be used to explain the
existence of I-nodes within a functional module. Given their
‘‘linker’’ position and the observation that they often share
similar annotated function with their neighboring M-nodes
(data not shown), it is a logical prediction that I-nodes play a
role in AHR signaling that is functionally similar to their
modiﬁer neighbors. We propose that I-nodes most commonly
arise as the result of their essential gene nature (gray nodes in
the ﬁgure; nontestable in the deletion screen) or because they
represent a redundant gene product (white nodes in the
ﬁgures). We offer two examples that support this idea. First,
one essential gene I-node in the folding module, Cns1p, has
recently been reported to be involved in AHR signaling
(Miller 2002). Second, the possibility that white nodes may
often result from redundancy is supported by what we know
about Hsp90. The Hsc82p and Hsp82p proteins are yeast
orthologs of human Hsp90, a well-studied chaperone re-
quired for proper AHR folding (Pongratz et al. 1992; Carver
et al. 1994; Whitelaw et al. 1995). Under normal growth
conditions, Hsp82p and Hsc82p account for 7% and 93% of
the total ‘‘Hsp90 level,’’ respectively (Borkovich et al. 1989).
Thus, it is not surprising that Hsp82p was not identiﬁed as a
modiﬁer, since its deletion would have had little effect on the
total Hsp90 level in the cell (Figure 7A). Finally, white I-nodes
can also arise from weak modiﬁers that inﬂuenced AHR
signaling by less than 4-fold, e.g., Sba1p (ortholog of human
AHR modiﬁer p23) (Kazlauskas et al. 1999). In this regard,
although a choice of 4-fold was somewhat arbitrary, we found
that lowering the cutoff greatly increased the network
complexity without enhancing the statistical signiﬁcance of
the AHR–PIN (as compared with random PINs; data not
shown).
The AHR Employs a Multistep Transcriptional Mechanism
The composition of the transcriptional activation module
suggests that the AHR activates target genes via the
coordination of histone acetylation, ATP-dependent chro-
matin remodeling, and direct recruitment of basal RNA
polymerase II transcriptional apparatus (see Figure 7). We
base this idea on the observation that this functional module
is composed of components of the histone acetyltransferase
SAGA complex (homolog of the mammalian PCAF com-
plex)—Gcn5p, Spt3p, and Spt8p; components of the SWI/SNF
chromatin-remodeling complex—Snf12p and Swi3p; and a
subunit of the Srb–mediator complex—Srb2p (Grant et al.
1998; Myers et al. 1998; Peterson et al. 1998). This
interdependent requirement of three distinct classes of
transcriptionally relevant proteins is consistent with obser-
vations from mammalian cells, where the involvement of both
HAT and SWI/SNF coactivators in AHR signaling has been
reported, as has the direct interaction of the AHR with basal
transcriptional factors TBP, TFIIF, and TFIIB (Rowlands et al.
1996; Kobayashi et al. 1997; Swanson and Yang 1998;
Beischlag et al. 2002; Wang and Hankinson 2002). These
collective data support the idea that AHR transactivation is
mediated by a multicomponent, synergistic process.
Nuclear Translocation of the AHR
Our network analysis has also identiﬁed a functional
module that regulates the ligand-dependent translocation of
the AHR (see Figure 7). This nuclear translocation module
appears to be associated with the PASB domain, which is
known to play roles in both ligand binding and interaction
with chaperones (see Figure 4A). This observation is
consistent with the idea that ligand exposure releases the
AHR from the cytosolic chaperone anchors (Kazlauskas et al.
2001; Petrulis et al. 2003). Although the mechanism for this
translocation event remains unclear, it is interesting to note
that the ‘‘translocation module’’ overlaps with a protein
degradation cluster, cluster 10 (see Figure 7A). This observa-
tion suggests that the underlying control of subcellular
localization of the AHR might be related to the selective
degradation of certain tethering factors by ubiquitination,
possibly mediated by Doa1p and other members in this
module (Hochstrasser and Varshavsky 1990).
Regulation of AHR Expression
A module that regulates the amount of receptor protein
was also identiﬁed in our AHR–PIN (see Figure 7). This
module is associated with the C-terminal domain of the AHR
(see Figure 4A). Although we have commonly referred to this
region as the TAD domain, these data suggest that other
functions are also encoded here. We base this assessment on
two observations. First, members of this module are not
known to play direct roles in transcription (see Table S4).
Second, this module inﬂuences receptor level in a manner
that is upstream of the AHR’s activity as a transcription
factor. Our interpretation of this module is that these
modiﬁers are associated with a domain that is proximal to
or overlaps with the receptor’s TAD and that this domain
plays a role in the regulation of receptor level (see Figure 4A).
At the present time it is not clear whether this module
inﬂuences the AHR at its mRNA or protein level.
A Novel Step Defined by the PASB Module
A novel PASB-dependent step in AHR signaling appears to
have been revealed by this network analysis (see Figure 7,
PASB-related module). Given that corresponding deletions of
this PASB-related module did not impair the receptor’s
nuclear translocation (see Figure 6, group I), we conclude that
this module must inﬂuence either a downstream nuclear
event or some cytosolic event that is not revealed until the
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The AHR Networkreceptor is within the nuclear compartment. On the other
hand, this module did not appear to be involved in the ﬁnal
transactivation step, as it was distinct from the trans-
activation module according to our functional annotations
(see Figures 4 and 5). Taken in sum, there must exist a PASB-
dependent event that is posttranslocation and pretransacti-
vation. Such an event could be related to the receptor’s
dimerization, DNA binding, or an as-yet-undeﬁned nuclear
event, such as the unfolding of a transcriptionally active
domain (Sun et al. 1997; Heid et al. 2000). Interestingly, the
existence of this PAS-related signaling is consistent with the
previous observation that the DNA binding ability of the
AHR can be impaired by a point mutation within its PAS
domain (Sun et al. 1997). Lastly, the fact that this PASB-
related module overlaps with multiple network clusters (1, 2,
8, 9) suggests a cooperative mechanism that involves more
than one cellular function (see Figure 7A).
Conclusion
We began this study with the objective of deﬁning the AHR
signal transduction pathway in a manner that would allow us
to quantify the number of loci and enumerate the steps
involved in signaling. By integrating our deletion screen with
the PIN framework and through subsequent computational
and experimental annotations, we were able to identify
modiﬁer modules that regulate ﬁve distinct AHR signaling
steps. In this regard, we found that the integration of multiple
annotation approaches is vital for the reconstruction of the
ﬁnal picture by connecting and cross-validating individual
information pieces. As interaction datasets become more
fully developed and annotated, such a map will steadily
improve and provide more accurate description of AHR
signaling. Lastly, the systematic strategy that we developed in
this work should be readily applicable to the study of most
mammalian proteins to reconstruct corresponding modiﬁer
networks that regulate their signaling.
Materials and Methods
Strains and plasmids. A set of deletion derivatives of S. cerevisiae
strain BY4742 (MATa, his3D1, leu2D0, lys2D0, ura3D0) was used in this
study. This deletion set was obtained from Research Genetics (now a
part of Invitrogen, Carlsbad, California, United States) in a 96-well
arrayed format. The plasmid pCEN-AHR (PL1605) was constructed
by replacing the TRP1 autotrophic marker of PL883 (Hogenesch
1999) with a HIS3 marker using a ‘‘marker swap’’ method (Cross
1997). This CEN-based plasmid contains the LexA–AHR chimera
cDNA (LexA-AHRND166) under the control of an alcohol dehydro-
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The AHR Networkgenase I (ADH1) promoter. LexA-AHRND166 is a chimeric AHR, with
its amino acid residues 1–166 replaced by residues 1–202 of bacterial
repressor LexA, and is referred to in the Results section simply as
‘‘AHR’’ for convenience. The reporter plasmid pSH18–34 (PL623)
(Clontech, Palo Alto, California, United States) is a 2l-based, URA3-
selectable vector that contains the bacterial LacZ gene, as a reporter,
under the control of eight LexA-binding sites. The plasmid pEG202
(Clontech, Palo Alto, California, United States) is a 2l-based, HIS3-
selectable plasmid containing the LexA1–202 sequence under the
control of the ADH1 promoter. The plasmid pAHR (PL700) has been
described previously (Carver 1996). This plasmid contains the
AHRND166 sequence inserted into the EcoRI site of pEG202. The
pGal4TAD control plasmid (PL1573) (Display Systems Biotech, now
NeuroSearch A/S, Ballerup, Denmark) contains the transcription
activation domain of yeast GAL4 inserted into the EcoRI site of
pEG202. The control plasmid pAHRDPASB (PL1799) is the same as
pAHR except for the removal of the C-terminal half of the PAS
domain. This pAHRDPASB plasmid was constructed by subcloning
the EcoRI fragment of PL248 (Carver et al. 1998) into the EcoRI site
of pEG202. The plasmid pAHRGFP (PL1890) was constructed as
follows: the GFPS65T cassette (Heim et al. 1995) was ampliﬁed by PCR
from pRSETBGFPS65T (PL1803) (a generous gift from Dr. Catherine





amplicon was cloned into the DraIII-digested pAHR by a gap repair
method (Lundblad and Zhou 1997). The resulting plasmid was
designated PL1855. The coding sequence for amino acids 1–166 of





amplicon was cloned into the PmeI/MluI-digested PL1855 by gap
repair. The resultant plasmid was designated pAHRGFP (PL1890).
High throughput yeast deletion array transformation. A high-
throughput protocol was developed for 96-well transformation based
on work previously described (Chen et al. 1992). Unless otherwise
noted, all steps were performed with a Hydra 96-channel dispenser
(Robbins Scientiﬁc, Sunnyvale, California, United States) and a vortex
mixer with a microwell plate adaptor (#12-812 and #12-812C, Fisher
Scientiﬁc, Hampton, New Hampshire, United States). Deletion strains
were stored in a stack of 96-well plates (–80 8C). For transformation,
each stock plate was thawed and cells were gently resuspended by
vortexing. About 0.5 ll of each strain culture was transferred to a 96-
well round bottom target plate (Costar #3795, Corning Inc., Acton,
Massachusetts, United States) containing 96 ll per well of yeast
extract–peptone–dextrose (YPD) medium plus G418 (200 mg/l). This
transfer was accomplished with a 96-pin disposable replicator
(GenomeSystems, now Incyte Genomics, Palo Alto, California, United
States). The inoculum was incubated at 308C without shaking until the
OD600 absorbance of individual wells reached 0.2–0.7 (approximately
18 h). The OD600 was measured using a SpectraMax 250 microplate
reader (Molecular Devices, Sunnyvale, California, United States).
Cells were then subjected to centrifugation at 3,500 rpm for 8 min,
and the supernatant was decanted. The 96-well plates were placed
upside-down on a stack of paper towels for 10 min to drain residual
medium. For transformation, each plate was vortexed at maximal
speed for 15 s before dispensing 22 ll of DNA in ‘‘OneStep’’ buffer
(V1M LiAc:V50% PEG 3350 = 1:4, with BME added to 0.77% V before use)
into each well. To make the DNA in ‘‘OneStep’’ buffer, one volume of
DNA (5 lg/ll ssDNA, 0.1 lg/ll each plasmid DNA) was mixed
vigorously by vortexing with ten volumes of ‘‘OneStep’’ buffer. After
DNA was dispensed, the plate was quickly vortexed again at maximal
speed for 10 s to resuspend the cells, followed by incubation at 458C
for 40 min. After this ‘‘heat shock’’ step, 5 ll of the transformation
mix from each well was inoculated into a fresh 96-well ﬂat-bottomed
plate containing 96 ll per well of dropout medium without Trp, Ura,
and His (dropout minus TUH medium) plus G418. The inoculum was
gently mixed by vortexing and incubated at 308C for about 4 d until
transformants grew out.
The 384-well ﬂuorescence assay for LacZ reporter. To perform the
LacZ reporter assay, transformants from the 96-well plates were
rearrayed into 384-well stock plates containing 30 ll per well of
dropout minus TUH medium. The inoculum was incubated at 308C
for 2–3 d to allow cell growth. For the LacZ reporter assay at each
agonist concentration, 0.5 ll of cell culture was transferred from the
384-well stock plate (308C) into a clear-bottomed/black-walled 384-
well assay plate (Falcon #353962, Becton Dickinson, Franklin Lakes,
New Jersey, United States) using a disposable 384-pin replicator
(GenomeSystems/Incyte Genomics). In the 384-well assay plate, each
well contained 18 ll of dropout minus TUH medium (diluted 1:4 in
Figure 7. Regulatory Network of AHR
Signaling
(A) The summary map of AHR–PIN.
Functional modules were determined
by the overlapped annotations from
three experimental layers (domain inﬂu-
ence, pharmacology clustering, and lo-
calization inﬂuence) as well as from
network clustering. For each functional
module, the main ‘‘stacking pattern’’ of
experimental layers is noted in italics.
Modiﬁers initially left outside the single
large cluster of the AHR–PIN were
assigned to corresponding functional
modules by sharing the similar stacking
pattern where applicable. See the legend
of Figure 3 for the color scheme of the
nodes and links.
(B) An expanded model of AHR signal-
ing. The AHR signaling pathway is
regulated by at least ﬁve functional
modules that are involved in the control
of receptor folding, nuclear transloca-
tion, transcriptional activation, receptor
level, and a PASB-related nuclear event.
Within each functional module, modi-
fers intially enclosed in the single large
cluster of the AHR–PIN are highlighted
in bold. Known human homologs of the
modiﬁers are noted at the side with a
smaller font (Costanzo et al. 2001) .
ARNT is dimmed because modiﬁers were
identiﬁed in this study from an ‘‘ARNT-
free’’ chimeric AHR system. See text for
details.
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The AHR Networkwater) plus agonist at the tested concentration. The plates were then
incubated at 308C for 48 h to allow all strains to reach stationary
phase. Cell growth was monitored by measuring the OD600 of each
well using a SpectraMax Plus
384 microplate reader (Molecular
Devices). To initiate the ﬂuorescence assay, 18 ll of lysis/assay buffer
was added to each well. Lysis/assay buffer contained a mixture of CUG
substrate (#F-2905, Molecular Probes, Eugene, Oregon, United
States), 10% SDS, 1 M NaPO4, and 253 TAE in the ratio of
1:1.4:350:17.5. For assays with pCEN-AHR transformants, no TAE
was required. Plates were vortexed at medium speed for 1 min and
left at room temperature for 20 min. The reaction was stopped by
dispensing 6.5 llo f2 5 3 TAE to each well and vortexing at medium
speed for 1 min. The ﬂuorescence emission of each well was detected
using a Wallac ‘‘VICTOR V’’ microplate reader (Perkin-Elmer,
Boston, Massachusetts, United States). The ﬂuorescence reading was
normalized to the corresponding OD600 value to obtain the LacZ
reporter activity of each deletion strain.
In vivo microscopic analysis of AHR–GFP localization. Selected
deletion strains were transformed with the plasmid pAHRGFP.
Transformants were incubated in a 96-well microtiter plate contain-
ing 100 ll per well of dropout minus TH medium at room
temperature. Given that we have observed that small temperature
shifts can affect AHR’s localization, we found it more convenient to
both grow and examine cells at the same temperature. For some
samples, assays were repeated at 308C using a heating chamber
attached to the microscope. Such results were found to be
comparable to those obtained at room temperature. For strains that
reached early log phase, 0.5 ll of culture was mounted on a glass slide,
and the AHR–GFP subcellular localization was examined using a Zeiss
(Oberkochen, Germany) Axiovert 200M microscope (a Plan-FLUAR
1003 objective). Images were captured using an AxioCam HR digital
microscope camera (Zeiss). To stain the nucleus in living cells, 4,6-
diamidino-2-phenylindole (DAPI) was added to the dropout minus
TH medium to a ﬁnal concentration of 5 lg/ml.
Modiﬁer identiﬁcation and network analysis. To identify deletions
that modify AHR signaling, the LacZ reporter activity of each deletion
strain was compared to the average of wt BY4742 strain controls
included in the same plate, and the fold change was obtained and log2
transformed. These data-processing steps, as well as subsequent
modiﬁer selection, were performed automatically using Perl scripts
written ‘‘in house.’’ In brief, for the primary screen involving 4,507
deletion strains with low-copy pCEN-AHR system, a stringent cutoff
of 4-fold change over wt control was chosen for selecting a pool of
most signiﬁcant AHR signaling mutants. This cutoff corresponds to a
p value of less than 10
–6 at all six assessed concentrations (null
distribution: wt control). The initial positives were subject to
validation and characterization in secondary screens with high-copy
pAHR and control systems. The cutoffs for control pathways
pGal4TAD and pAHRDPASB in the secondary screens were chosen
at 2-fold change over wt control, which corresponds to p values of 3.3
3 10
–2 and 5.6 3 10
–4 (null distribution: wt control), respectively.
For PIN construction, the main physical interaction table was
downloaded from the DIP database (http://dip.doe-mbi.ucla.edu) and
the genetic interaction table from the MIPS database (http://
mips.gsf.de/proj/yeast/). Perl scripts, written ‘‘in house,’’ were used
to search the combined physical and genetic interaction database and
identify all valid paths (less than or equal to Dmax) that linked each
pair of modiﬁers. The network graph was rendered using the
Graphviz tool kit (http://www.research.att.com/sw/tools/graphviz/) (Ell-
son et al. 2004).
Within experimental annotation layers of the AHR–PIN, the
region corresponding to each functional module was outlined by a
closed line (boundary) drawn manually on the network map. This
boundary was delineated to include the maximal number of modiﬁer
nodes that are members of the corresponding functional module and
the minimal number of modiﬁer nodes that are nonmembers. This
boundary was also deﬁned in such a way that all enclosed modiﬁer
nodes were interconnected via paths within the enclosed region or
through at most one modiﬁer node outside. When deﬁning func-
tional modules in the summary AHR–PIN, the highest weight was
given to the results from the localization inﬂuence experiments
because these results provided the most direct indication of a
modiﬁer’s effect on AHR signaling, and the lowest weight was given to
the pharmacology clustering result because this result was highly
sensitive to the choice of clustering algorithm.
Supporting Information
Table S1. Signiﬁcant AHR Modiﬁers
This table contains all of the ORFs whose corresponding deletion
strains reproducibly displayed a signiﬁcant change in AHR signaling
compared to wt BY4742 strain. Also shown are their known gene
names, products, gene descriptions, and Gene Ontology (GO)
annotations (Ashburner et al. 2000; Issel-Tarver et al. 2002).
Found at DOI: 10.1371/journal.pbio.0020065.st001 (35 KB XLS).
Table S2. AHR-Speciﬁc Modiﬁers
This table contains all of the ORFs that were observed to inﬂuence
the signaling of the AHR but not the pGal4TAD control. Also shown
are their known gene names, products, gene descriptions, and GO
annotations (Ashburner et al. 2000; Issel-Tarver et al. 2002).
Found at DOI: 10.1371/journal.pbio.0020065.st002 (27 KB XLS).
Table S3. YPD Annotation of AHR Modiﬁers
This table summarizes the annotation on cellular functions of AHR
modiﬁers. The annotation was derived from the YPD database, as of
May 2002 (Costanzo et al. 2001) .
Found at DOI: 10.1371/journal.pbio.0020065.st003 (23 KB XLS).
Table S4. M-Nodes in the AHR–PIN
This table contains all of the AHR modiﬁers that were interconnected
in the AHR–PIN (Dmax = 2). Also shown are their known gene names,
products, gene descriptions, and GO annotations (Ashburner et al.
2000; Issel-Tarver et al. 2002).
Found at DOI: 10.1371/journal.pbio.0020065.st004 (24 KB XLS).
Table S5. Functional Enrichment of Network Clusters
This table summarizes the functional enrichment of each network
cluster as calculated by the hypergeometric distribution of MIPS and
GO annotations. For each cluster, the functional enrichment is
determined by using M-nodes alone and both M- and I-nodes,
respectively. In each case, the annotation that corresponds to the
largest number of nodes in the cluster and the smallest p value is
shown (k, number of genes from the query cluster in the given
category; f, total number of genes in the given category).
Found at DOI: 10.1371/journal.pbio.0020065.st005 (22 KB XLS).
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